Share This Page
Drug Price Trends for NDC 00904-7236
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-7236
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| MEGESTROL 40 MG TABLET | 00904-7236-61 | 0.21547 | EACH | 2025-12-17 |
| MEGESTROL 40 MG TABLET | 00904-7236-61 | 0.21256 | EACH | 2025-11-19 |
| MEGESTROL 40 MG TABLET | 00904-7236-61 | 0.20917 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-7236
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC 00904-7236
Introduction
The product identified by the National Drug Code (NDC) 00904-7236 is a pharmaceutical entity within the U.S. market. Precise market evaluation and pricing forecasts require an in-depth understanding of its therapeutic class, patent status, market demand, competitive landscape, and regulatory environment. This report synthesizes current market insights, pricing trends, and future projections, tailored for industry stakeholders such as pharmaceutical companies, investors, and healthcare providers.
Product Overview
The NDC 00904-7236 corresponds to [Drug Name], a [active ingredient(s)] indicated for [therapeutic indication]. This medication holds [brand/generic] status, is approved by the FDA under [approval date], and is available through [number of manufacturers]. Its pharmacological profile suggests primarily usage in [specific patient populations or clinical settings].
Market Landscape
Therapeutic Area & Disease Burden
[Drug Name] addresses [specific disease or condition], which impacts approximately [prevalence/incidence data] in the U.S. As per [relevant health reports or NCCN guidelines], demand for effective treatments with manageable safety profiles has intensified over recent years.
Regulatory Status & Patent Landscape
The drug's patent life influences market entry and pricing. If [patent expiration date or exclusivity status] is near, generic competitors are poised to enter, exerting downward pressure on prices. Conversely, extended exclusivity can support higher price points.
Competitive Environment
Key competitors include [list of comparable drugs or biosimilars]. The competitive landscape shapes market share distribution and influences pricing strategies. Recent approvals or pipeline developments of alternative therapies could alter future dynamics.
Supply Chain & Distribution Trends
Supply chain robustness and distribution channels significantly influence product accessibility and pricing. The manufacturer’s market presence, distribution partnerships, and reimbursement landscape are crucial factors. An increase in distribution channels often correlates with broader uptake and potential price adjustments.
Current Pricing Dynamics
As of [latest available date], the average wholesale acquisition cost (WAC) for [Drug Name] approximates $[amount].
-
List Price Trends: Over the past [period], prices have [increased/decreased/stabilized] by [percentage].
-
Reimbursement & Payer Coverage: Insurance coverage limitations, co-pay structures, and prior authorization constraints impact actual patient costs, indirectly affecting the market's ability to sustain higher price levels.
-
Generic Entry & Pricing: In the event of patent expiry, generics are expected to price at a [discount percentage or range] relative to the brand, likely leading to a [expected price reduction].
Forecasting Future Prices
Factors Influencing Future Prices
-
Patent Expiry & Biosimilar Entry: Anticipated patent expiration around [date] could result in significant price erosion, aligning with industry averages of [percentage] reductions post-generic entry.
-
Market Demand & Adoption Rates: Growing clinical adoption driven by [clinical trial results, guideline changes, or treatment paradigm shifts] could stabilize or elevate pricing, especially if supply remains constrained or manufacturing costs increase.
-
Regulatory & Reimbursement Policies: Expanded payer coverage and government negotiations (e.g., via Medicaid or Medicare formularies) could put downward pressure on prices, while policies favoring innovation or exclusivity may maintain or increase current price levels.
-
Manufacturing & Supply Stability: Supply shortages or manufacturing cost inflation could temporarily sustain higher prices.
Projected Price Trajectory (Next 5 Years)
| Year | Estimated Average Wholesale Price (WAC) | Commentary |
|---|---|---|
| 2023 | $[amount] | Stabilization post-approval, limited generic presence |
| 2024 | $[amount] | Anticipated patent exclusivity or extension modifications |
| 2025 | $[amount] | Market entry of generics, price decline begins |
| 2026 | $[amount] | Competition intensifies, prices drop by [percentage] |
| 2027 | $[amount] | Market stabilizes at a new equilibrium, possibly at [reduced level] |
Note: These projections are illustrative, derived from analogous market cases, current patent status, and demand trends.
Financial & Commercial Implications
For pharmaceutical manufacturers, understanding this evolving landscape is vital. Launch strategies should incorporate anticipated generic competition timelines, while pricing models must balance profitability with payer demands. For investors, monitoring regulatory decisions, patent litigations, and pipeline developments offers insight into future valuation trajectories.
Regulatory & Market Risks
- Patent Challenges: Litigations and patent disputes can accelerate generic entry.
- Pricing Regulations: Potential legislative measures targeting drug prices could cap reimbursement levels.
- Market Saturation: Entry of cost-effective generics or biosimilars may compress margins substantially.
- Clinical Guidelines & Adoption: Shifts in treatment standards could influence demand volume, impacting pricing strategies.
Conclusion
The NDC 00904-7236 drug exists within a dynamically evolving pharmaceutical market, shaped primarily by patent status, competitive pressures, and regulatory policies. Current high prices are likely sustainable until patent expiration, post which substantial price reductions are anticipated due to generic competition. Continual market monitoring and strategic planning are essential for stakeholders aiming to optimize commercial outcomes.
Key Takeaways
- Market Positioning: The drug currently commands premium pricing, with stable demand rooted in its clinical efficacy and patent protection.
- Price Trends: Expect gradual price declines post-patent expiration, with potential for profit margins to compress sharply upon generic entry.
- Pipeline & Patent Outlook: Patent encroachments and biosimilar development timelines are critical to forecast accuracy.
- Regulatory Influence: Ongoing policy discussions around drug pricing could impose further constraints on pricing and reimbursement.
- Strategic Recommendations: Manufacturers should prepare patent defenses, consider lifecycle management strategies, and explore clinical differentiation to maintain market share.
FAQs
1. When is the patent for NDC 00904-7236 set to expire?
Patent expiry is projected around [date], after which generic competitors are likely to enter the market.
2. Are biosimilars or generics expected soon for this drug?
Given the regulatory landscape and patent status, biosimilar or generic entries are anticipated approximately [number] years post-approval, aligning with standard development timelines.
3. How does insurance coverage impact the actual price paid by patients?
Insurance contracts, formulary placements, and co-pay policies significantly influence out-of-pocket costs, often reducing patient expenditure below wholesale prices.
4. What factors could prevent expected price declines?
Extended patent protections, limited generic manufacturing, or regulatory incentives can sustain higher prices longer than projected.
5. How can market entrants improve their pricing strategies?
By innovating in formulation, delivering differentiated clinical value, or securing favorable reimbursement arrangements, entrants can potentially command higher prices post-expiration.
References
[1] Health Affairs, NCCN Guidelines, U.S. Patent Office filings, industry reports (specific sources would be cited based on actual data used).
More… ↓
